Article: | MedLuna.com

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2018 Feb 17

PMID 29449259

Authors

Nav Persaud

Affiliations

Soon will be listed here.

References

Gana T, Pascual M, Fleming R, Schein J, Janagap C, Xiang J . Extended-release tramadol in the treatment of osteoarthritis: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Curr Med Res Opin. 2006; 22(7):1391-401. DOI: 10.1185/030079906X115595. View

Rauck R, Rapoport R, Thipphawong J . Results of a double-blind, placebo-controlled, fixed-dose assessment of once-daily OROS® hydromorphone ER in patients with moderate to severe pain associated with chronic osteoarthritis. Pain Pract. 2012; 13(1):18-29. DOI: 10.1111/j.1533-2500.2012.00555.x. View

Rudd R, Aleshire N, Zibbell J, Gladden R . Increases in Drug and Opioid Overdose Deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64(50-51):1378-82. DOI: 10.15585/mmwr.mm6450a3. View

Adams E, Breiner S, Cicero T, Geller A, Inciardi J, Schnoll S . A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006; 31(5):465-76. DOI: 10.1016/j.jpainsymman.2005.10.006. View

Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik J . The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain. Evid Rep Technol Assess (Full Rep). 2018; (218):1-219. DOI: 10.23970/AHRQEPCERTA218. View

Ghate S, Haroutiunian S, Winslow R, McAdam-Marx C . Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies. J Pain Palliat Care Pharmacother. 2010; 24(3):251-8. DOI: 10.3109/15360288.2010.501851. View

Banta-Green C, Merrill J, Doyle S, Boudreau D, Calsyn D . Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients. Drug Alcohol Depend. 2009; 104(1-2):34-42. PMC: 2716214. DOI: 10.1016/j.drugalcdep.2009.03.021. View

Fleming M, Davis J, Passik S . Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med. 2008; 9(8):1098-106. PMC: 2779534. DOI: 10.1111/j.1526-4637.2008.00491.x. View

Finkelstein Y, Macdonald E, Gonzalez A, Sivilotti M, Mamdani M, Juurlink D . Overdose Risk in Young Children of Women Prescribed Opioids. Pediatrics. 2017; 139(3). DOI: 10.1542/peds.2016-2887. View

10.

Cowan D, Wilson-Barnett J, Griffiths P, Allan L . A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med. 2004; 4(4):340-51. DOI: 10.1111/j.1526-4637.2003.03038.x. View

11.

Dowell D, Haegerich T, Chou R . CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016; 65(1):1-49. DOI: 10.15585/mmwr.rr6501e1. View

12.

Kaplovitch E, Gomes T, Camacho X, Dhalla I, Mamdani M, Juurlink D . Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study. PLoS One. 2015; 10(8):e0134550. PMC: 4546305. DOI: 10.1371/journal.pone.0134550. View

13.

Han B, Compton W, Jones C, Cai R . Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013. JAMA. 2015; 314(14):1468-78. DOI: 10.1001/jama.2015.11859. View

14.

Vorsanger G, Xiang J, Gana T, Pascual M, Fleming R . Extended-release tramadol (tramadol ER) in the treatment of chronic low back pain. J Opioid Manag. 2008; 4(2):87-97. DOI: 10.5055/jom.2008.0013. View

15.

Manchikanti L, Pampati V, Damron K, Beyer C, Barnhill R, Fellows B . Prevalence of prescription drug abuse and dependency in patients with chronic pain in western Kentucky. J Ky Med Assoc. 2003; 101(11):511-7. View

16.

Hojsted J, Nielsen P, Guldstrand S, Frich L, Sjogren P . Classification and identification of opioid addiction in chronic pain patients. Eur J Pain. 2010; 14(10):1014-20. DOI: 10.1016/j.ejpain.2010.04.006. View

17.

Passik S, Messina J, Golsorkhi A, Xie F . Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain. J Pain Symptom Manage. 2010; 41(1):116-25. DOI: 10.1016/j.jpainsymman.2010.03.012. View

18.

Mangel A, Bornstein J, Hamm L, Buda J, Wang J, Irish W . Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2008; 28(2):239-49. DOI: 10.1111/j.1365-2036.2008.03730.x. View

19.

Dhalla I, Mamdani M, Sivilotti M, Kopp A, Qureshi O, Juurlink D . Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ. 2009; 181(12):891-6. PMC: 2789126. DOI: 10.1503/cmaj.090784. View

20.

Bohnert A, Logan J, Ganoczy D, Dowell D . A Detailed Exploration Into the Association of Prescribed Opioid Dosage and Overdose Deaths Among Patients With Chronic Pain. Med Care. 2016; 54(5):435-41. PMC: 6626611. DOI: 10.1097/MLR.0000000000000505. View